KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Operating Margin (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Operating Margin for 17 consecutive years, with 21.01% as the latest value for Q4 2025.

  • On a quarterly basis, Operating Margin rose 1656.0% to 21.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.56%, a 3671.0% increase, with the full-year FY2025 number at 9.56%, up 3671.0% from a year prior.
  • Operating Margin was 21.01% for Q4 2025 at Bristol Myers Squibb, down from 2.62% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 1.8% in Q1 2023 to a low of 121.77% in Q1 2024.
  • A 5-year average of 14.01% and a median of 6.58% in 2022 define the central range for Operating Margin.
  • Peak YoY movement for Operating Margin: plummeted -12357bps in 2024, then surged 12122bps in 2025.
  • Bristol Myers Squibb's Operating Margin stood at 4.16% in 2021, then plummeted by -55bps to 6.44% in 2022, then plummeted by -45bps to 9.33% in 2023, then crashed by -303bps to 37.57% in 2024, then soared by 44bps to 21.01% in 2025.
  • Per Business Quant, the three most recent readings for BMY's Operating Margin are 21.01% (Q4 2025), 2.62% (Q3 2025), and 13.03% (Q2 2025).